| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.03 |